CSIMarket
 


Quidelortho Corp  (QDEL)
Other Ticker:  
 


Quidelortho's Operating Profit Margin by quarter

Trends, Rankings, Statistics



QDEL Operating Profit Margin (Jul 03 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change 247.32 % 167.03 % -21.3 % 7.07 % -12.46 %
Seq. Revenue Change -38.8 % 57.37 % 24.94 % 188.62 % -52.95 %
Revenue In Millions $613.40 $1,002.26 $636.87 $509.74 $176.61
Operating Profit Margin 12.99 % 61.93 % 59.15 % 55.29 % 13.2 %
Operating Profit Margin Total Ranking # 1518 # 179 # 298 # 218 # 1681
Operating Income In Millions $79.70 $620.66 $376.73 $281.84 $23.31
Y / Y Operating Income Change 241.97 % 176.85 % -38.95 % -8.48 % -72.14 %
Seq. Operating Income Change -87.16 % 64.75 % 33.67 % 1109.31 % -89.6 %


Commenting Second Quarter 2022 Operating Profit Margin
Quidelortho Corp experienced contraction in Operating Income by -87.16 % to $613 millions and Revenue by -38.8 %, while Operating Profit Margin fell to 12.99 %, below company's average Operating Profit Margin.

Observing second quarter 2022 results within In Vitro & In Vivo Diagnostic Substances industry 2 other companies have achieved higher Operating Profit Margin. While Operating Profit Margin overall ranking has deteriorated compare to previous quarter from 179 to 1518.
Explain Operating Margin
QDEL's Operating Profit Margin second quarter 2022 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 3
Healthcare Sector # 102
Overall # 1518

Operating Profit Margin Statistics
High Average Low
76.26 % 25.8 % 0.39 %
(Dec 31 2020)   (Jun 30 2018)




Other Operating Profit Margin Profitability Ratios
QDEL's Cumulative Operating Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Operating Profit Margin Trends and Statistics
Healthcare Sector Operating Profit Margin Statistics
Operating Profit Margin Profitability Trends for overall market
QDEL's Operating Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Operating Profit Margin
Lowest Ranking Operating Profit Margin
Operating Profit Margin Profit Margin for QDEL's Competitors
Operating Profit Margin Profit Margin for Quidelortho's Suppliers
Operating Profit Margin Profit Margin for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Operating Income Growth
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons


Companies with similar Operating Profit Margin in the quarter ending Jul 03 2022, within In Vitro & In Vivo Diagnostic Substances Industry Operating Profit MarginJul 03 2022 MRQ Operating IncomeJul 03 2022 MRQ Revenue
Lantheus Holdings Inc.  28.25 %$ 63.204 $ 223.723 
Idexx Laboratories Inc  20.81 %$ 179.066 $ 860.546 
Quidelortho Corp  12.99 %$ 79.700 $ 613.400 
Neogen Corporation  12.87 %$ 18.027 $ 140.093 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PDII's Profile

Stock Price

PDII's Financials

Business Description

Fundamentals

Charts & Quotes

PDII's News

Suppliers

PDII's Competitors

Customers & Markets

Economic Indicators

PDII's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071